|
|
Article: Alexza Appoints Andrew L. Busser to Board of Directors.
- Article from:
- Biotech Week
- Article date:
- October 7, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced that Andrew L. Busser has been appointed to its Board of Directors. Mr. Busser is currently a Partner, Managing Member and Co-Founder of Symphony Capital LLC. Mr. Busser was nominated to be appointed to the Alexza Board of Directors, pursuant to the terms of Alexza's agreement to acquire the outstanding equity of Symphony Allegro, which was completed on August 26, 2009 (see also Alexza Pharmaceuticals, Inc.).
Prior to founding Symphony Capital, Mr. Busser co-founded Wilkerson Partners LLC, a management consulting firm, in August 2000. From May 1997 to March 2000, Mr. Busser served as a management consultant with ...